Matthias Stelljes

45PUBLICATIONS
219CO-AUTHORS
Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 08, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

|Jul 02, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

|Jun 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|Apr 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.

Alexandros Kanellopoulos, Linda Koster, Hugues de Lavallade

Pageof 8

Frequent Collaborators

12 joint publications

Wolfgang Bethge

12 joint publications

Nicolaus Kröger

11 joint publications

Mohamad Mohty

10 joint publications

Jakob R Passweg